EMA — authorised 8 August 1996
- Marketing authorisation holder: VIIV HLTHCARE
- Status: approved
EMA authorised Epivir on 8 August 1996
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. EMA authorised it on 8 August 1996.
VIIV HLTHCARE holds the EU marketing authorisation.